KCM
Knoll Capital Management Portfolio holdings
AUM
$141M
This Quarter Return
+7.92%
1 Year Return
+51.8%
3 Year Return
+256.4%
5 Year Return
+482.18%
10 Year Return
+5,137.57%
AUM
$66.3M
AUM Growth
+$66.3M
(+16%)
Cap. Flow
+$9.15M
Cap. Flow
% of AUM
13.79%
Top 10 Holdings %
Top 10 Hldgs %
93.04%
Holding
21
New
4
Increased
2
Reduced
2
Closed
4
Top Buys
1 |
Corbus Pharmaceuticals
CRBP
|
$9.69M |
2 |
Summit Therapeutics
SMMT
|
$1.33M |
3 |
NTRP
Neurotrope, Inc. Common
NTRP
|
$867K |
4 |
Evoke Pharma
EVOK
|
$543K |
5 |
Amicus Therapeutics
FOLD
|
$357K |
Top Sells
1 |
ADXS
Advaxis, Inc.
ADXS
|
$1.61M |
2 |
Theriva Biologics
TOVX
|
$1.55M |
3 |
NBSE
NeuBase Therapeutics, Inc. Common Stock
NBSE
|
$306K |
4 |
Enlivex Therapeutics
ENLV
|
$214K |
5 |
Qualigen Therapeutics
QLGN
|
$213K |
Sector Composition
1 | Healthcare | 99.25% |